Crombez Eric 4

What Happened

• Eric Crombez, a director of Abeona Therapeutics, sold 16,284 common shares on 2026-02-02 in open-market/private transactions. The weighted-average price reported was $5.09, with the sale proceeds totaling approximately $82,895. This was a sale (S) and the filing notes the disposition was to cover tax obligations from the vesting of restricted stock awards—an often routine, non-investment-driven transaction.

Key Details

• Transaction date: 2026-02-02
• Price: weighted average $5.09; actual sale prices ranged from $5.09 to $5.12 (multiple transactions) (see footnote F2)
• Shares sold: 16,284; gross proceeds ≈ $82,895
• Reason given: sale to cover tax obligations associated with vesting of restricted stock awards (footnote F1)
• Shares owned after the transaction: not disclosed in the provided excerpt
• Filing timeliness: reported on 2026-02-02 (same day as the transaction date provided)

Context

• Sales to cover tax withholding on vested awards are common and do not necessarily signal a director’s negative view of the company. Retail investors generally view purchases as more informative about insider sentiment; this transaction appears to be administrative in nature. If you want the exact post-transaction holdings or a breakdown of how many shares sold at each price within the $5.09–$5.12 range, the filer says they will provide that detail upon request (per footnote F2).